Smakman Niels, Borel Rinkes Inne H M, Voest Emile E, Kranenburg Onno
Department of Surgery G04-228, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3508GA Utrecht, The Netherlands.
Biochim Biophys Acta. 2005 Nov 25;1756(2):103-14. doi: 10.1016/j.bbcan.2005.07.001. Epub 2005 Aug 10.
Mutational activation of the K-Ras proto-oncogene is frequently observed during the very early stages of colorectal cancer (CRC) development. The mutant alleles are preserved during the progression from pre-malignant lesions to invasive carcinomas and distant metastases. Activated K-Ras may therefore not only promote tumor initiation, but also tumor progression and metastasis formation. Metastasis formation is a very complex and inefficient process: Tumor cells have to disseminate from the primary tumor, invade the local stroma to gain access to the vasculature (intravasation), survive in the hostile environment of the circulation and the distant microvascular beds, gain access to the distant parenchyma (extravasation) and survive and grow out in this new environment. In this review, we discuss the potential influence of mutant K-Ras on each of these phases. Furthermore, we have evaluated the clinical evidence that suggests a role for K-Ras in the formation of colorectal metastases.
在结直肠癌(CRC)发展的极早期阶段,经常观察到K-Ras原癌基因的突变激活。从癌前病变发展到浸润性癌和远处转移的过程中,突变等位基因得以保留。因此,激活的K-Ras不仅可能促进肿瘤起始,还可能促进肿瘤进展和转移形成。转移形成是一个非常复杂且低效的过程:肿瘤细胞必须从原发肿瘤播散,侵入局部基质以进入脉管系统(血管内渗),在循环和远处微血管床的恶劣环境中存活,进入远处实质组织(血管外渗),并在这个新环境中存活和生长。在这篇综述中,我们讨论了突变型K-Ras对这些阶段中每个阶段的潜在影响。此外,我们评估了提示K-Ras在结直肠癌转移形成中起作用的临床证据。